ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱟᱡᱟᱨ ᱒᱐᱑᱙


ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱟᱡᱟᱨ ᱒᱐᱑᱙ ᱥᱮ ᱠᱳᱵᱷᱤᱰ-᱑᱙ ᱢᱤᱫ ᱯᱟᱥᱱᱟᱣᱚᱜ ᱟᱡᱟᱨ ᱠᱟᱱᱟ ᱡᱟᱦᱟᱸ ᱫᱚ ᱟᱹᱰᱤ ᱜᱟᱹᱦᱤᱨ ᱛᱮ ᱥᱟᱦᱮᱫ ᱭᱚᱱᱟᱛᱨᱚ ᱨᱮ ᱟᱡᱟᱨ ᱥᱤᱨᱡᱚᱱᱮᱫ ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱒ (ᱥᱟᱨᱥ-ᱠᱳᱵᱷ-᱒) ᱧᱩᱛᱩᱢᱟᱱ ᱢᱤᱫ ᱞᱮᱠᱟᱱ ᱵᱷᱟᱭᱨᱟᱥ ᱨᱮᱭᱟᱜ ᱚᱨᱥᱚᱝ ᱛᱮ ᱦᱩᱭᱩᱜᱼᱟ ᱾ ᱱᱚᱣᱟ ᱟᱡᱟᱨ ᱫᱚ ᱥᱟᱱᱟᱢ ᱠᱷᱚᱱ ᱞᱟᱦᱟ ᱒᱐᱑᱙ ᱥᱮᱨᱢᱟ ᱨᱮᱭᱟᱜ ᱰᱤᱥᱮᱢᱵᱚᱨ ᱪᱟᱸᱫᱚ ᱨᱮ ᱪᱤᱱ ᱫᱤᱥᱚᱢ ᱨᱮ ᱥᱟᱵᱽ ᱧᱟᱢ ᱞᱮᱱᱟ ᱾

ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱟᱡᱟᱨ ᱒᱐᱑᱙
(ᱠᱳᱵᱷᱤᱰ-᱑᱙)
ᱮᱴᱟᱜ ᱧᱩᱛᱩᱢ ᱠᱚᱠᱳᱵᱷᱤᱰ, ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ
ᱵᱤᱥᱮᱥᱚᱛᱛᱚInfectious disease
ᱞᱚᱠᱠᱷᱚᱱᱨᱩᱣᱟᱹ, ᱠᱷᱳᱜ, ᱞᱟᱸᱜᱟ, ᱥᱟᱦᱮᱫ ᱠᱚᱥᱴᱚ, ᱡᱚᱢᱼᱧᱩ ᱨᱮ ᱥᱤᱵᱤᱞ ᱵᱟᱝ ᱵᱩᱡᱷᱟᱹᱣ;
ᱠᱚᱢᱯᱞᱤᱠᱮᱥᱟᱱᱱᱤᱣᱢᱳᱱᱤᱭᱟ, ᱵᱷᱟᱭᱨᱟᱞ ᱥᱮᱯᱥᱤᱥ, ᱮᱠᱭᱩᱴ ᱨᱮᱥᱯᱤᱨᱮᱴᱳᱨᱤ ᱰᱤᱥᱤᱥ ᱥᱤᱱᱰᱨᱳᱢ, ᱡᱚᱨᱭᱟ ᱛᱷᱩᱞᱤ ᱵᱟᱹᱲᱤᱡ, ᱵᱟᱝ ᱥᱟᱦᱮᱫ ᱫᱟᱲᱮ
ᱮᱛᱚᱦᱚᱵ ᱚᱠᱛᱚᱥᱚᱝᱠᱨᱚᱢᱚᱱ ᱠᱷᱚᱱ ᱒–᱑᱔ ᱢᱟᱦᱟᱸ (ᱥᱟᱫᱷᱟᱨᱚᱱ ᱕)
ᱚᱠᱛᱚ5 days to chronic
ᱚᱡᱮᱟᱹᱰᱤ ᱜᱟᱹᱦᱤᱨ ᱛᱮ ᱥᱟᱦᱮᱫ ᱭᱚᱱᱟᱛᱨᱚ ᱨᱮ ᱟᱡᱟᱨ ᱥᱤᱨᱡᱚᱱᱮᱫ ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱒ (ᱥᱟᱨᱥ-ᱠᱳᱵᱷ-᱒)
ᱟᱡᱟᱨ ᱴᱷᱟᱹᱣᱠᱟᱹᱭ ᱦᱚᱨᱟrRT-PCR ᱵᱤᱰᱟᱹᱣ, ᱥᱤ.ᱴᱤ ᱥᱠᱮᱱ, ᱨᱮᱯᱤᱰ ᱮᱱᱴᱤᱡᱮᱱ ᱴᱮᱥᱴ
ᱫᱟᱯᱟᱨᱟᱢᱢᱮ ᱱᱷᱟᱦᱟ ᱵᱮᱫ, ᱠᱣᱟᱨᱮᱱᱴᱟᱭᱤᱱ, ᱦᱚᱨᱢᱚ/ᱥᱟᱶᱛᱟ ᱥᱟᱺᱜᱤᱧ (ᱥᱳᱥᱤᱭᱟᱞ ᱰᱤᱥᱴᱮᱱᱥᱤᱝ), ᱵᱷᱮᱱᱴᱤᱞᱮᱥᱟᱱ, ᱛᱤ ᱟᱹᱨᱩᱵ
ᱛᱤᱠᱤᱪᱷᱟᱹᱥᱤᱢᱴᱳᱢᱮᱴᱤᱠ ᱟᱨ ᱜᱚᱲᱚᱣᱟᱭ
ᱜᱷᱚᱴᱚᱱ ᱨᱮᱭᱟᱜ ᱫᱚᱨ᱑᱙᱙,᱕᱖᱖,᱐᱔᱙[᱑] ᱴᱷᱤᱠᱟᱹ ᱟᱠᱟᱱ ᱨᱩᱜᱤ
ᱜᱚᱡ ᱜᱩᱨ ᱮᱞ᱔,᱒᱔᱖,᱒᱐᱒[᱑]

ᱱᱚᱣᱟ ᱟᱡᱟᱨ ᱨᱮᱭᱟᱜ ᱞᱚᱠᱠᱷᱚᱱ ᱞᱮᱠᱟᱛᱮ ᱨᱩᱣᱟᱹ ᱮᱢᱟᱱ ᱞᱚᱠᱠᱷᱚᱱ ᱠᱚ ᱧᱮᱞᱚᱜᱼᱟ ᱾ ᱵᱷᱟᱭᱨᱟᱥ ᱥᱟᱶ ᱡᱚᱯᱨᱟᱣ ᱢᱤᱫ ᱠᱷᱚᱱ ᱜᱮᱯᱩᱱ ᱢᱟᱦᱟᱸ ᱢᱩᱸᱫᱽ ᱨᱮ ᱱᱚᱣᱟ ᱞᱚᱠᱠᱷᱚᱱ ᱠᱚᱫᱚ ᱧᱮᱞᱚᱜᱼᱟ ᱾ ᱥᱚᱝᱠᱨᱚᱢᱚᱱ ᱛᱟᱭᱚᱢ ᱱᱚᱣᱟ ᱟᱡᱟᱨ ᱛᱮ ᱜᱩᱨ ᱨᱮᱭᱟᱜ ᱫᱚᱨ ᱜᱷᱩᱸᱴ ᱓.᱔%, ᱡᱟᱦᱟᱸ ᱨᱮ ᱒᱐ ᱥᱮᱨᱢᱟ ᱠᱷᱚᱱ ᱠᱚᱢ ᱩᱢᱮᱨ ᱨᱮᱱ ᱨᱩᱜᱤ ᱟᱜ ᱫᱚᱨ ᱐.᱒% ᱟᱨ ᱘᱐ ᱥᱮᱨᱢᱟ ᱠᱷᱚᱱ ᱰᱷᱮᱨ ᱩᱢᱮᱨ ᱨᱮᱱ ᱦᱚᱲᱟᱜ ᱫᱚ ᱑᱕% ᱾

ᱧᱩᱛᱩᱢ ᱥᱟᱯᱲᱟᱣ

ᱩᱦᱟᱱ ᱨᱮ ᱯᱩᱭᱞᱩ ᱯᱟᱥᱱᱟᱣ ᱚᱠᱛᱚ, ᱱᱚᱣᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱟᱨ ᱟᱡᱟᱨ ᱫᱚ "ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ" ᱟᱨ "ᱩᱦᱟᱱ ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ" ᱧᱩᱛᱩᱢ ᱛᱮ ᱧᱩᱢᱩᱜ ᱠᱟᱱ ᱛᱟᱦᱮᱱᱟ ᱟᱫᱚᱢ ᱡᱚᱠᱷᱮᱡ ᱟᱡᱟᱨ ᱥᱟᱶᱛᱮ "ᱩᱦᱟᱱ ᱱᱤᱣᱢᱳᱱᱤᱭᱟ" ᱧᱩᱛᱩᱢ ᱦᱚᱠᱚ ᱞᱟᱹᱭᱮᱫ ᱛᱟᱦᱮᱱᱟ ᱾ ᱥᱟᱢᱟᱝ ᱛᱟᱞᱢᱟ ᱨᱮᱥᱯᱤᱨᱮᱴᱳᱨᱤ ᱥᱤᱱᱰᱨᱳᱢ ᱟᱨ ᱡᱤᱠᱟ ᱵᱷᱟᱭᱨᱟᱥ ᱾ ᱡᱟᱱᱩᱣᱟᱨᱤ ᱒᱐᱒᱐ ᱨᱮ ᱦᱩ ᱫᱚ ᱵᱷᱟᱭᱨᱟᱥ ᱟᱨ ᱟᱡᱟᱨ ᱞᱟᱹᱜᱤᱫ ᱒᱐᱑᱙-ᱮᱱᱠᱳᱵᱷ ᱟᱨ ᱒᱐᱑᱙-ᱮᱱᱠᱳᱵᱷ ᱮᱠᱭᱩᱴ ᱨᱮᱥᱯᱤᱨᱮᱴᱳᱨᱤ ᱰᱤᱥᱤᱥ ᱛᱟᱞᱢᱟ (Interim) ᱧᱩᱛᱩᱢ ᱮ ᱥᱩᱯᱟᱨᱤᱥ ᱞᱮᱫᱟ, ᱡᱟᱦᱟᱸ ᱫᱚ ᱒᱐᱑᱕ ᱨᱮᱭᱟᱜ ᱫᱤᱥᱼᱦᱩᱫᱤᱥ ᱟᱨ ᱚᱛᱱᱚᱜ ᱴᱚᱴᱷᱟ (ᱡᱮᱞᱮᱠᱟ: ᱩᱦᱟᱱ, ᱪᱤᱱ), ᱡᱟᱱᱩᱣᱟᱨ, ᱡᱟᱹᱛ ᱥᱮ ᱦᱚᱲ ᱜᱩᱥᱴᱤ ᱨᱮᱭᱟᱜ ᱧᱩᱛᱩᱢ ᱵᱤᱨᱩᱫᱽ ᱡᱮᱜᱮᱛᱟᱹᱨᱤ ᱫᱤᱥᱼᱦᱩᱫᱤᱥ ᱞᱮᱠᱟᱛᱮ ᱫᱚᱦᱚ ᱦᱩᱭ ᱟᱠᱟᱱᱟ ᱾ ᱑᱑ ᱡᱟᱱᱩᱣᱟᱨᱤ ᱒᱐᱒᱐ ᱨᱮ ᱦᱩ ᱫᱚ ᱱᱚᱣᱟ ᱨᱮᱭᱟᱜ ᱥᱚᱨᱠᱟᱨᱤ ᱧᱩᱛᱩᱢ ᱠᱳᱵᱷᱤᱰ-᱑᱙ ᱟᱨ ᱥᱟᱨᱥ-ᱠᱳᱵᱷ-᱒ ᱮ ᱩᱪᱷᱟᱹᱱ ᱞᱮᱫᱟ ᱾ ᱦᱩ ᱨᱮᱱ ᱢᱟᱬᱛᱮ ᱟᱸᱫᱮᱭᱟᱹ ᱴᱮᱰᱨᱳᱥ ᱟᱫᱷᱟᱱᱳᱢ ᱮ ᱞᱟᱹᱭ ᱟᱠᱟᱫᱟ ᱠᱳ ᱫᱚ ᱠᱚᱨᱳᱟᱱ, ᱵᱷᱤ ᱫᱚ ᱵᱷᱟᱭᱨᱟᱥ, ᱰ ᱫᱚ ᱟᱡᱟᱨ ᱟᱨ ᱑᱙ ᱫᱚ ᱯᱩᱭᱞᱩ ᱪᱤᱱᱦᱟᱹ ᱟᱠᱟᱱ (᱓᱑ ᱰᱤᱥᱮᱢᱵᱚᱨ ᱒᱐᱑᱙) ᱮ ᱵᱩᱡᱷᱟᱹᱣ ᱚᱪᱚᱭᱮᱫᱟ ᱾[᱒]

ᱪᱤᱱᱦᱟᱹ ᱠᱚ ᱟᱨ ᱞᱚᱠᱠᱷᱚᱱ ᱠᱚ ᱥᱟᱯᱲᱟᱣ

ᱚᱡᱮ (ᱠᱟᱨᱚᱱ) ᱥᱟᱯᱲᱟᱣ

ᱫᱟᱯᱟᱨᱟᱢ ᱥᱟᱯᱲᱟᱣ

ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱟᱡᱟᱨ ᱒᱐᱑᱙ (ᱠᱳᱵᱷᱤᱰ-᱑᱙) ᱢᱮᱱ ᱫᱚ ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱥᱚᱝᱠᱨᱚᱢᱚᱱ ᱫᱟᱯᱟᱨᱟᱢ ᱞᱟᱹᱜᱤᱫ ᱞᱟᱹᱠᱛᱤᱭᱟᱱ ᱠᱟᱛᱷᱟ ᱫᱚ ᱞᱟᱛᱟᱨ ᱨᱮ ᱚᱞ ᱥᱚᱫᱚᱨ ᱮᱱᱟ ᱾ ᱱᱚᱸᱰᱮ ᱫᱤᱥᱟᱹ ᱫᱚᱦᱚ ᱦᱩᱭᱩᱜᱼᱟ ᱦᱮ, ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱦᱚᱲ ᱴᱷᱮᱱ ᱠᱷᱚᱱ ᱦᱚᱲ ᱴᱷᱮᱱ ᱵᱟᱨ ᱞᱮᱠᱟᱛᱮ ᱯᱟᱥᱱᱟᱣ ᱫᱟᱲᱮᱭᱟᱜᱼᱟ ᱾ ᱮᱛᱚᱦᱚᱵ ᱥᱚᱝᱠᱨᱚᱢᱚᱱ ᱫᱚ ᱵᱟᱨᱭᱟ ᱛᱷᱚᱠ ᱨᱮ ᱦᱩᱭᱩᱜᱼᱟ ᱾ ᱮᱛᱚᱦᱚᱵ ᱛᱷᱚᱠ: ᱠᱚᱨᱳᱱᱟ ᱧᱟᱢ ᱟᱠᱟᱫᱤ ᱢᱤᱫ ᱦᱚᱲ ᱚᱲᱟᱜ ᱵᱟᱨᱦᱮ ᱥᱮᱱ ᱠᱟᱛᱮ ᱢᱩᱼᱢᱚᱪᱟ ᱵᱟᱝ ᱵᱮᱸᱫᱽ ᱠᱟᱛᱮ ᱮ ᱠᱷᱳᱜ ᱞᱮᱠᱷᱟᱱ ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱩᱱᱤ ᱟᱸᱰᱮᱼᱯᱟᱥᱮ‌ (᱑-᱒ ᱢᱤᱴᱟᱨ ᱵᱮᱨᱦᱟᱭ ᱛᱮ) ᱨᱮᱭᱟᱜ ᱦᱚᱭ ᱨᱮ ᱵᱟᱨᱼᱯᱮ ᱴᱟᱲᱟᱝ ᱫᱷᱟᱹᱵᱤᱡ ᱛᱟᱦᱮ ᱫᱟᱲᱮᱭᱟᱜᱼᱟ ᱾ ᱫᱚᱥᱟᱨ ᱛᱷᱚᱠ: ᱚᱱᱟ ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱢᱮᱱᱟᱜ ᱦᱚᱭ ᱨᱮ ᱮᱴᱟᱜ ᱦᱚᱲ ᱠᱚᱠᱚ ᱥᱟᱦᱮᱫ ᱞᱮᱠᱷᱟᱱ ᱩᱱᱠᱩᱣᱟᱜ ᱥᱟᱦᱮᱫ ᱛᱟᱞᱟ ᱛᱮ ᱤᱱᱵᱚᱨᱚ ᱨᱮ ᱠᱚᱨᱳᱱᱟᱵᱷᱟᱭᱨᱟᱥ ᱵᱚᱞᱚ ᱫᱟᱲᱮᱭᱟᱜᱼᱟ ᱾

ᱟᱨᱦᱚᱸ ᱧᱮᱞ ᱢᱮ ᱥᱟᱯᱲᱟᱣ

ᱵᱟᱨᱦᱮ ᱡᱚᱱᱚᱲ ᱥᱟᱯᱲᱟᱣ

ᱦᱮᱞᱛᱷ ᱮᱢᱮᱱᱥᱤ ᱥᱟᱯᱲᱟᱣ

Directories ᱥᱟᱯᱲᱟᱣ

Medical journals ᱥᱟᱯᱲᱟᱣ

Treatment guidelines ᱥᱟᱯᱲᱟᱣ

  • "JHMI Clinical Recommendations for Available Pharmacologic Therapies for COVID-19" (PDF). The Johns Hopkins University.
  • "Bouncing Back From COVID-19: Your Guide to Restoring Movement" (PDF). The Johns Hopkins School of Medicine. Archived from the original (PDF) on 2021-02-15. Retrieved 2021-08-04.
  • "Guidelines on the Treatment and Management of Patients with COVID-19" (PDF). Infectious Diseases Society of America. Lay summary. {{cite web}}: Cite uses deprecated parameter |lay-url= (help)
  • "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines" (PDF). National Institutes of Health. Lay summary. {{cite web}}: Cite uses deprecated parameter |lay-url= (help)
  • World Health Organization (2021). Therapeutics and COVID-19: living guideline, 6 July 2021 (Report). hdl:10665/342368. WHO/2019-nCoV/therapeutics/2021.2. Lay summary. {{cite report}}: Cite uses deprecated parameter |lay-url= (help)
  • NHS England and NHS Improvement. National Guidance for post-COVID syndrome assessment clinics (PDF) (Report). Archived from the original (PDF) on 2021-03-29. Retrieved 2021-08-04. Lay summary. {{cite report}}: Cite uses deprecated parameter |lay-url= (help)

ᱥᱟᱹᱠᱷᱹᱭᱟᱹᱛ ᱥᱟᱯᱲᱟᱣ